- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
Total 1138 results
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
ImmunityBio, Inc.Active, not recruiting
-
PharmalinkActive, not recruitingNon-muscle-invasive Bladder CancerSpain
-
University of OklahomaEMD SeronoCompletedBladder CancerUnited States
-
Jørgen Bjerggaard JensenCepheidActive, not recruitingNon-muscle Invasive Bladder Cancer | Urinary BiomarkerDenmark
-
West China HospitalRemeGen Co., Ltd.Not yet recruitingNon-muscle Invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenNovo Nordisk A/S; University of AarhusRecruitingNon-muscle Invasive Bladder CancerDenmark, Norway, Latvia
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
University of Rome Tor VergataUniversity of BariCompleted
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
Mayo ClinicRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Ferring PharmaceuticalsRecruiting
-
University College, LondonAstraZeneca; ShionogiRecruitingBladder CancerUnited Kingdom
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Shanghai Jiatan Pharmatech Co., LtdRecruitingGastric Type Adenocarcinoma (GAS) With STK11 MutationChina
-
Lisata Therapeutics, Inc.RecruitingCholangiocarcinoma | Bile Duct Cancer | Intrahepatic Cholangiocarcinoma | Gallbladder Carcinoma | Gallbladder Cancer | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | Gall Bladder CarcinomaUnited States, Spain
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Fox Chase Cancer CenterRecruitingRenal Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Ureter Cancer | Urethral CancerUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Fidia Farmaceutici s.p.a.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)Italy
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Aarhus University HospitalActive, not recruitingNon-muscle Invasive Bladder CancerDenmark
-
Meir Medical CenterRecruitingKidney Cancer | Prostate Cancer | Bladder CancerIsrael
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingAdrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaUnited States
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityNot yet recruitingBladder Cancer | Renal CancerBelarus
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedCarcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
National Cancer Institute (NCI)CompletedUrinary Bladder NeoplasmsUnited States
-
GV20 TherapeuticsRecruitingCholangiocarcinoma | Non-small Cell Lung Cancer | Endometrial Carcinoma | Head and Neck Carcinoma | Cutaneous Melanoma | Solid Tumor, Adult | Refractory Cancer | Adenocarcinoma of the Rectum | Bladder Urothelial Carcinoma | Adenocarcinoma of the ColonUnited States
-
Istituto Oncologico Veneto IRCCSFidia Farmaceutici s.p.a.Not yet recruiting
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
National Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States
-
Endo PharmaceuticalsCompletedCarcinoma in Situ | Bladder CancerUnited States
-
Dokuz Eylul UniversityNot yet recruitingBladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical InstillationTurkey
-
University of California, DavisNational Cancer Institute (NCI)RecruitingGastric Carcinoma | Lung Carcinoma | Malignant Neoplasm | Bladder Carcinoma | Liver and Intrahepatic Bile Duct CarcinomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Active, not recruitingEfficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCChina